The invention relates to compounds of formula (I):
1
wherein:
R
1
, R
2
and R
3
are as defined in the description,
X is as defined in the description,
Y represents an oxygen atom, a sulphur atom, a C(H)q group, SO or S0
2
,
n is equal to from 0 to 5,
A represents a NR
5
R
6
or CZNR
8
R
9
group.
and medicinal products containing the same are useful in treating or in preventing melatoninergic disorders.
COMPOSES HETEROCYCLIQUES, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT
申请人:ADIR ET COMPAGNIE
公开号:EP0998471A1
公开(公告)日:2000-05-10
US6313160B1
申请人:——
公开号:US6313160B1
公开(公告)日:2001-11-06
US6602903B2
申请人:——
公开号:US6602903B2
公开(公告)日:2003-08-05
[EN] SUBSTITUTED HETEROCYCLIC COMPOUNDS, METHOD FOR PREPARING AND COMPOSITIONS CONTAINING SAME<br/>[FR] COMPOSES HETEROCYCLIQUES, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT
申请人:ADIR ET COMPAGNIE
公开号:WO1998052935A1
公开(公告)日:1998-11-26
(EN) The invention concerns compounds of formula (I) in which: R1, R2 and R3 are as define in the description; X is as defined in the description; Y represents an oxygen atom, a sulphur atom, a CHq, SO or SO2 group; n is between 0 and 5; A represents a NR5R6 or CZNR8R9 group. The invention is useful for preparing medicines.(FR) L'invention concerne les composés de formule (I), dans laquelle: R1, R2 et R3 sont tels que définis dans la description, X est tel que défini dans la description, Y représente un atome d'oxygène, un atome de soufre, un groupement CHq, SO ou SO2, n vaut 0 à 5, A représente un groupement NR5R6 ou CZNR8R9; médicaments.